Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.2500 (-3.14%) ($5.2500 - $5.2500) on Wed. Jan. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.94% (three month average) | RSI | 70 | Latest Price | $5.2500(-3.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 16.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) CEMB(75%) TLT(53%) VCIT(47%) TIP(44%) UNG(36%) | Factors Impacting CAPR price | CAPR will decline at least -2.47% in a week (0% probabilities). TBT(-35%) XLE(-46%) OIH(-35%) EWP(-31%) XLF(-28%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.47% (StdDev 4.94%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.97(5.63%) | 10 Day Moving Average | $4.64(13.15%) | 20 Day Moving Average | $4.24(23.82%) | To recent high | -3.1% | To recent low | 0% | Market Cap | $103m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |